Drug could reduce COVID-19 hospitalization, death by 89%


Pfizer reported that its experimental COVID-19 drug has shown highly positive results in helping patients avoid hospitalization and death from the virus. Infectious disease expert Dr. John Sanders said the medication, combined with a low dose of the HIV drug ritonavir, "will have a major impact on how we treat COVID-19."

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.